Atrial Fibrillation Rate Control Therapy Guided By Continuous Ambulatory Monitoring

Withdrawn before enrolling · Not applicable

Conditions studied: Atrial Fibrillation

In brief

The purpose of this study is to demonstrate that the use of a continuous ambulatory monitoring device will reduce both the time to effective rate control and the health care expenditures associated with standard methods of rate control monitoring in patients presenting with atrial fibrillation with a rapid heart rate.

Key facts

Study ID

NCT00115843

Run by

Beth Israel Deaconess Medical Center

People needed

0

Starts

2005-04-01

Expected to finish

2006-09-01

Last updated by the study team

2017-04-05

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Atrial fibrillation with resting ventricular rate > 100 with rate control strategy indicated
• Atrial fibrillation is likely to be recurrent or persistent in the clinical judgment of the physician
• Patient able to be managed out of the hospital
• Ability to sign informed consent
• Ability to wear electrodes for the Cardionet device
• Patient willing to have home patient educator install Cardionet monitor in their home

You may not qualify if…

• Inability to follow up with prescribed schedule of monitoring
• Concomitant use of antiarrhythmic drug
• Indication for hospitalization

Where it is running

• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.